Abstract
To assess the clinical impact of a molecular beacon (MB) assay that detects multidrug-resistant tuberculosis (MDR TB), we retrospectively reviewed records of 127 MDR TB patients with and without MB testing between 2004 and 2007. Use of the MB assay reduced the time to detection and treatment of MDR TB.
Original language | English (US) |
---|---|
Pages (from-to) | 3779-3781 |
Number of pages | 3 |
Journal | Journal of Clinical Microbiology |
Volume | 48 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2010 |
Externally published | Yes |
ASJC Scopus subject areas
- Microbiology (medical)